Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
59 /100
HIGH RISK
Score updated Oct 13, 2026

PBM — Psyence Biomedical Ltd. Dilution Risk Tracker

Track PBM dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track PBM — Get alerts when the score changes →

As of October 13, 2026, Psyence Biomedical Ltd. (PBM) has a DilutionWatch DilutionScore of 59/100, rated HIGH dilution risk. Psyence Biomedical Ltd. has a market capitalization of $10.87M, 2.29M shares outstanding, 5 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
40
📊 Float Risk
80
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for PBM.
🔔 Track PBM — Get forecast alerts →

Market Data

Market Cap$10.87M
Shares Outstanding2.29M
Float292.7K
Cash$7.15M
DebtN/A
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore59/100DilutionWatch score record
Shares Outstanding2.29MVerified float table or market cache
Public Float292.7KVerified float table or market cache
Market Cap$10.87MMarket data cache
Cash RunwayNot availableDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 3.

Recent SEC source mix: EFFECT 1, SC 13G 1, SC 13G/A 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

5 institutional holders · 158.0K shares
#1 Parallel Advisors, LLC 151.2K shares
#2 Stonehage Fleming Financial Services Holdings Limited 89 shares

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest26.8K
Days to Cover1.0
% of Float9.2%
FINRA data as of Sep 30, 2026

Recent SEC Activity

SC 13G BENEFICIAL OWNERSHIP 2026-10-05
EFFECT EFFECT 2026-09-01
SC 13G/A BENEFICIAL OWNERSHIP 2026-06-10
Full SEC filing analysis available with free account →

Recent News

Factual PBM Dilution Snapshot

Psyence Biomedical Ltd. (PBM) has a DilutionScore of 59/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

PBM's DilutionScore is currently 59/100 (High risk), with 4 score changes tracked over 89 days. The score deteriorated from 60/100 (High risk).

Period Score Risk Level Duration
Oct 11 – Oct 13, 202659/100HIGH3 days
Oct 05 – Oct 10, 202660/100HIGH6 days
Sep 24 – Oct 04, 202655/100HIGH11 days
Sep 14 – Sep 23, 202654/100HIGH10 days
Jul 16 – Sep 13, 202655/100HIGH59 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

PBM shares outstanding have increased 99.9% from 1.15M (Mar 2026) to 2.29M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 16, 20262.29M292.7K▲ 0.02%
Mar 07, 20261.15M292.6K▲ 2.42%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track PBM Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment PBM files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking PBM — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for PBM
PBM FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.